Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan
Mini Review
Molecular Biomarkers\' Impact on Diagnosis: Advancing Precision Oncology
Author(s): Shargeo Kawaguchi*
The pursuit of precision medicine has long been a goal. Traditional cancer treatments often used a uniform approach, effective for some but
inadequate for many. Yet, technological advances and molecular biomarkers have revolutionized cancer diagnosis and treatment. These molecular
signals enable tailored therapies, enhancing outcomes and patient care. Precision oncology is a transformative strategy considering each patient's
tumour's unique molecular features. Unlike the old one-size-fits-all approach, it personalizes treatment based on specific genetic changes fuelling
tumour progression. By harnessing molecular biomarkers, clinicians can better understand the underlying biology of cancer and identify targeted
therapies that offer the greatest chance of success... Read More»
DOI:
10.37421/2155-9929.2024.15.650
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report